|
2024
|
Invention
|
Pharmaceutical preparation.
Preparations including recombinant FSH (rFSH). |
|
2022
|
Invention
|
Methods for treating metastatic stage prostate cancer.
The invention provides methods and dosing... |
|
2021
|
Invention
|
Liquid pharmaceutical composition.
The present invention provides a physically and chemically st... |
|
|
Invention
|
Pharmaceutical preparation. Preparations including recombinant FSH (rFSH). |
|
2020
|
Invention
|
Liquid pharmaceutical composition. The present invention provides a physically and chemically sta... |
|
2018
|
Invention
|
Manufacturing of pharmaceutical compositions. The present disclosure discloses a process for the ... |
|
2017
|
Invention
|
Liquid-transfer adapter beveled spike. A liquid-transfer adapter operatively interposable between... |
|
2015
|
P/S
|
Pharmaceutical preparations for the treatment of sexual dysfunction. |
|
2014
|
Invention
|
Medicament for the treatment of endometriosis. The use of a dopamine agonist in the manufacture o... |
|
|
Invention
|
Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation. Preparations including recombinan... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of sexual dysfunction; unit-dose self-dispenser app... |
|
2013
|
Invention
|
Pharmaceutical composition.
A pharmaceutical composition comprising a docusate; an osmotic laxat... |
|
2011
|
Invention
|
Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof. Composit... |
|
2010
|
Invention
|
Oxytocin receptor agonists. The present invention relates to oxytocin receptor agonist compounds,... |
|
|
Invention
|
Kit and method for preparation of a degarelix solution.
A kit and method for preparing a Degarel... |
|
|
Invention
|
Pharmaceutical compositions and methods for the treatment of prostate cancer. Compositions, kits,... |
|
2009
|
Invention
|
Pharmaceutical composition suitable for use as foam comprising 5'-aminosalicylic acid and silicon... |
|
|
Invention
|
Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia. The p... |
|
|
Invention
|
Recombinant fsh including alpha 2,3- and alpha 2,6-sailylation. The present disclosure describes ... |
|
|
Invention
|
Antibody binding only to il6-sil6r complex. An antibody that binds strongly to human IL-6/sIL-6R ... |
|
|
Invention
|
Treatment of metastatic stage prostate cancer with degarelix. Compositions comprising degarelix f... |
|
|
Invention
|
Method of treating prostate cancer with the gnrh antagonist degarelix. The invention provides use... |
|
2008
|
Invention
|
Pharmaceutical composition. A pharmaceutical composition comprising a docusate; an osmotic laxati... |
|
|
Invention
|
Pharmaceutical compositon for cleansing of the bowel. A pharmaceutical composition comprising a d... |
|
|
Invention
|
Granular compositions of magnesium oxide and citric acid and uses thereof. Compositions are provi... |
|
|
Invention
|
Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, p... |
|
|
Invention
|
Syringe system with piston-barrel construction for improved sterilisation process. System for con... |
|
2007
|
Invention
|
Laminin-derived multi-domain peptides. Multi-domain peptides including a heparin-binding peptide ... |
|
|
Invention
|
Stable solid dosage form comprising desmopressin. The present invention relates to a novel pharma... |
|
2006
|
Invention
|
Use of antagonist of oxytocin and/or vasopressin in assisted reproduction.
The present invention... |
|
|
Invention
|
Use of antagonists of oxytocin and/or vasopressin in assisted reproduction. The present invention... |
|
|
Invention
|
Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist. Dis... |
|
2003
|
Invention
|
Medical injector and medicament loading system for use therewith. The present invention discloses... |
